New Preclinical Data from Dyne Therapeutics’ Myotonic Dystrophy Type 1 Program to be Featured in Presentations During Upcoming American Society of Gene & Cell Therapy Annual Meeting
Company to host webcast including leading DM1 expert, Dr. Charles Thornton, following presentations on May…
ESET Showcases Cutting-Edge AI Security at Black Hat 2026